Skip to main content

Population-based plasma lipidomics reveals developmental changes in metabolism and signatures of obesity risk: a mother-offspring cohort study

Abstract

Background

Lipids play a vital role in health and disease, but changes to their circulating levels and the link with obesity remain poorly characterized in expecting mothers and their offspring in early childhood.

Methods

LC-MS/MS-based quantitation of 480 lipid species was performed on 2491 plasma samples collected at 4 time points in the mother-offspring Asian cohort GUSTO (Growing Up in Singapore Towards healthy Outcomes). These 4 time points constituted samples collected from mothers at 26–28 weeks of gestation (n=752) and 4–5 years postpartum (n=650), and their offspring at birth (n=751) and 6 years of age (n=338). Linear regression models were used to identify the pregnancy and developmental age-specific variations in the plasma lipidomic profiles, and their association with obesity risk. An independent birth cohort (n=1935), the Barwon Infant Study (BIS), comprising mother-offspring dyads of Caucasian origin was used for validation.

Results

Levels of 36% of the profiled lipids were significantly higher (absolute fold change > 1.5 and Padj < 0.05) in antenatal maternal circulation as compared to the postnatal phase, with phosphatidylethanolamine levels changing the most. Compared to antenatal maternal lipids, cord blood showed lower concentrations of most lipid species (79%) except lysophospholipids and acylcarnitines. Changes in lipid concentrations from birth to 6 years of age were much higher in magnitude (log2FC=−2.10 to 6.25) than the changes observed between a 6-year-old child and an adult (postnatal mother) (log2FC=−0.68 to 1.18). Associations of cord blood lipidomic profiles with birth weight displayed distinct trends compared to the lipidomic profiles associated with child BMI at 6 years. Comparison of the results between the child and adult BMI identified similarities in association with consistent trends (R2=0.75). However, large number of lipids were associated with BMI in adults (67%) compared to the children (29%). Pre-pregnancy BMI was specifically associated with decrease in the levels of phospholipids, sphingomyelin, and several triacylglycerol species in pregnancy.

Conclusions

In summary, our study provides a detailed landscape of the in utero lipid environment provided by the gestating mother to the growing fetus, and the magnitude of changes in plasma lipidomic profiles from birth to early childhood. We identified the effects of adiposity on the circulating lipid levels in pregnant and non-pregnant women as well as offspring at birth and at 6 years of age. Additionally, the pediatric vs maternal overlap of the circulating lipid phenotype of obesity risk provides intergenerational insights and early opportunities to track and intervene the onset of metabolic adversities.

Clinical trial registration

This birth cohort is a prospective observational study, which was registered on 1 July 2010 under the identifier NCT01174875.

Peer Review reports

Background

Pregnancy is associated with changes to lipid metabolism as the gestation progresses [1]. These changes are essential to maintain a constant supply of nutrients to the gestating mother and the growing fetus [2]. Maternal dyslipidemia has been associated with pregnancy-related complications and perinatal outcomes such as preeclampsia, gestational diabetes, preterm birth, and macrosomia [3, 4]. There is also mounting evidence that in obese glucose-tolerant mothers, lipids contribute more strongly to excess fetal fat accretion than glucose [5, 6]. In utero nutrition plays a crucial role in fetal development. Sub-optimal in utero experience may not only influence the birth outcomes, but also alter the developmental programming to elevate the risk for chronic diseases later in life [7, 8]. However, molecular mechanisms, whereby antenatal nutrition affects fetal development, remain underexplored. Population-based studies have increased our understanding of metabolism related to maternal and child health outcomes [9,10,11,12,13]. However, there is a lack of population-level lipidomic studies to define longitudinal and intergenerational lipidomic profiles, as well as their association with adiposity. Here, we studied the changes to plasma lipidome of women during pregnancy (antenatal vs postnatal plasma), and their offspring during development (cord blood and 6-year-old child plasma) in the GUSTO (Growing Up in Singapore Towards healthy Outcomes) birth cohort. We also delineated the associations of plasma lipidomic profiles with pediatric and adult adiposity and studied their overlap. We validated these findings in an independent birth cohort, the Barwon Infant Study (BIS), comprising mother-offspring dyads of different ethnic origin (Caucasian), recruited using an unselected antenatal sampling frame in the southeast of Australia. This study provides a valuable resource for future developmental origins of health and disease (DOHaD) research.

Methods

Study participants and clinical characteristics

GUSTO (Growing Up in Singapore Towards healthy Outcomes) is a prospective mother–offspring cohort study in Singapore consisting of 1247 women recruited between June 2009 and September 2010 [14]. Study participants were of Chinese, Malay, or Indian ethnicity with both parents from the same ethnic background. Written informed consent was obtained at recruitment, and ethics approval for the study was granted by the Institute Review Board of KK Women’s and Children’s Hospital (KKH) and National University Hospital (NUH). This study was registered under ClinicalTrials.gov on 1 July 2010 under the identifier NCT01174875. The study was approved by Singhealth Centralised Institutional Review Board (CIRB) under CIRB Ref: 2018/2767. The study was conducted in accordance with the Declaration of Helsinki, and the lipidomics study was approved by the Institutional Review Board of National University of Singapore # H-17-055E. All subjects gave their informed consent for inclusion before they participated in this study.

Data on maternal age, ethnicity, education level, and self-reported pre-pregnancy weights were collected from the participants during recruitment. Pre-pregnancy body mass index (ppBMI) was calculated as pre-pregnancy weight divided by height squared. Antenatal BMI was calculated as weight measured at 26–28 weeks of gestation divided by height squared. Gestational weight gain (GWG) up to 26–28 weeks of pregnancy and total GWG were calculated by subtracting self-reported pre-pregnancy weights from weights measured at 26–28 weeks of gestation and weights measured at delivery, respectively. For offspring born to the women enrolled in this study, information on gestational age, birth weight, sex, and birth order were retrieved from birth delivery reports. At postnatal follow-up visit, age, weight, and height of mothers were collected at 4–5 years after delivery. Age, weight, and height of children were collected at 6-year-old. Postnatal maternal BMI and child BMI were calculated accordingly.

The Barwon Infant Study (BIS) is a major birth cohort study being conducted by the Child Health Research Unit (CHRU) at Barwon Health in collaboration with the Murdoch Children’s Research Institute (MCRI) and Deakin University [15]. The association studies with birth weight and pre-pregnancy BMI were used for replication of findings in GUSTO cohort.

Sample selection, preparation and experimental design

A total of 2519 plasma samples collected after overnight fasting from GUSTO cohort were selected for this lipidomics study. These consisted of antenatal maternal samples (n=763) collected at 26–28 weeks of pregnancy, cord blood samples (n=767) collected at delivery, postnatal maternal (n=651) collected at 4–5 years after delivery, and child samples (n=338) collected at 6 years of age. All plasma samples were prepared in 10 aliquots for lipid extraction. A pooled quality control was prepared from a subset of the representative samples from the study. This pooled QC was then used to prepare a batch QCs (BQC) and a technical QCs (TQC). These QCs serve well-defined roles of monitoring and correcting for biases introduced during sample preparation, LC-MS/MS-based measurements as well as for determining signal-to-noise ratios, coefficient of variation of individual lipid species, linearity and stability of the analytical platform. A stratified randomization strategy was used to allocate the samples into seven batches. Paired samples were measured in the same batch. At the same time, blanks, process blanks (PBLK), and aliquots of reference plasma samples from NIST-1950 were interspersed in between the samples. QCs and blanks were processed and analyzed along with the study samples within each batch.

Lipid extraction and LC-MS/MS analysis

The samples were extracted according to the stratified randomization template and 438 samples (study samples as well as QCs) were extracted in one batch with a total of seven batches for the current study. Lipid extraction was carried out using butanol: methanol (extraction solvent) in a ratio of 1:1 containing 10 mM ammonium formate and deuterated or non-physiological internal standards as described previously [16]. A total of 100 μL of extraction solvent was added to each sample, vortexed for 10 s followed by sonication for 60 min with temperature maintained at 18–22 °C. The samples were centrifuged at speed of 13,000 rpm for 10 min. The supernatant (80 μL) was collected in mass spectrometry compatible vials and stored at −80 °C for LC-MS/MS. These lipid extracts were analyzed by using Agilent 6490 QQQ mass spectrometer interfaced with an Agilent 1290 series HPLC system. Lipids were separated on a ZORBAX RRHD UHPLC C18 column (2.1×100 mm 1.8 mm, Agilent Technologies) with the thermostat set at 45 °C. Targeted LC-MS/MS was performed in ESI positive ion mode with dynamic multiple reaction monitoring (dMRM). Mass spectrometry settings and MRM transitions for each lipid class, subclass, and individual species were kept as described previously [17, 18]. The following mass spectrometer parameters were used: gas temperature, 150 °C, gas flow rate 17L/min, nebulizer 20psi, sheath gas temperature 200 °C, capillary voltage 3500V, and sheath gas flow 10L/min. Isolation widths were set to unit resolution for both Q1 and Q3. QC samples were analyzed along with the samples to monitor sample extraction efficiency as well as LC-MS performance and were subsequently used to do batch corrections.

Pre-processing of data

Peak integration was carried out in MassHunter Quantitative software (Agilent Technologies) to select area of each individual lipid species. Manual inspection was carried out to ensure that correct peaks were picked at specific retention time. Peak areas along with retention times were exported as .csv for further analysis. These data were filtered by using a cut-off for signal-to-noise ratio (S/N>10) and linear response (R2>0.8) of each lipid species. Peak areas of lipid species were normalized to their class specific internal standard as described previously [17, 18]. Batch QCs was used to correct signal drifts across the batches based on LOESS [19] regression method (locally polynomial regression fitting, span=0.75, R version 3.5.1). Following that, lipid species were dropped if quality control coefficient of variation was greater than 20%. These stringent quality control steps enabled us to measure lipid species with precision (average CV = 9.8%). The approach applied here provides relative quantitation as the use of isotope-labeled internal standards required for absolute quantitation of each lipid species under investigation is not feasible. Finally, a total of 480 lipid species representing 25 lipid classes were used for the downstream data analysis. In addition, we removed 27 outlier samples based on principal component analysis (Additional file 1: Fig. S1) and one cord blood sample without sex information which resulted in 2491 samples for further downstream analysis.

Statistical analysis

All lipidomics data were log10 transformed for the downstream analyses. The unsupervised principal component analysis of lipid species data from all the samples was applied to estimate overall differences between the four sample groups (antenatal mother (n=752), cord blood (n=751), postnatal mother (n=650), and child (n=338)). Postnatal maternal plasma lipidomic profiles (average age = 36 years and not pregnant) was used as a proxy for adult samples for comparison with child lipidomic profiles. As the sample size of each group is different, both cross-sectional and paired analyses were applied to four comparative lipidomics studies (postnatal vs. antenatal, cord blood vs. antenatal, child vs. cord blood and adult vs. child). Cross-sectional analysis used all the available samples in each group. Linear regression models were applied using lipid levels as outcomes and groups as predictors. Potential confounders were examined by checking their associations with the top ten principal components of the specific lipidomic dataset in each comparison study and then the selected confounders were adjusted in the regression models accordingly. In the comparison study of antenatal and postnatal lipidomic profiles, ethnicity, maternal age, maternal education level, and pre-pregnancy BMI were adjusted. For the comparison between antenatal and cord blood lipidomic profiles, ethnicity, maternal age, maternal education level, pre-pregnancy BMI, infant sex, gestational age, and birth weight were adjusted. Sex, ethnicity, maternal education level, gestational age, and birth weight were adjusted in the comparison study of cord blood and child lipidomic profiles. For the comparison between child and adult (postnatal mother) lipidomic profiles, sex, ethnicity, BMI, and maternal education level were adjusted. In addition, paired t-test was also applied to compare group difference using paired samples with a much smaller sample size (Additional file 1: Fig. S2; postnatal vs. antenatal: 381 pairs; cord blood vs. antenatal: 445 pairs; child vs. cord blood: 237 pairs and adult vs. child: 272 pairs) and the results were compared to the linear regression results. The regression coefficients (β) were converted to log2 fold change (FC=10β). The adjusted p-values (Padj) were calculated by the Benjamini-Hochberg (BH) method. The lipid species with |FC|>1.5 and Padj<0.05 were considered significant in the above comparative studies.

Similarly, association of lipids with BMI or birth weight was studied in the four sample groups using linear regression. Both ppBMI and antenatal BMI were studied in antenatal lipidome. ppBMI was studied after accounting for the effects of maternal ethnicity, education, age, and gestational weight gain at 26–28 weeks of pregnancy. Antenatal BMI was studied after the adjustment of maternal ethnicity, education, and age. Child BMI and adult (postnatal) BMI were examined in child lipidome and postnatal mother lipidome, respectively. Child BMI was studied after the adjustment of child sex, ethnicity, and maternal education, while adult BMI was studied after accounting for the effects of ethnicity, maternal education, and age. As birth weight (BW) is widely used as a risk factor for overweight/obesity in pediatrics [20], BW was investigated in cord blood lipidome after the adjustment of sex, ethnicity, maternal age, maternal education, pre-pregnancy BMI, total gestational weight gain, gestational age, and birth order. The regression coefficients (β) were converted to % change in lipid concentration per unit BMI (ppBMI, child BMI and adult BMI), or % change in lipid concentration per 100 grams of BW (% change = (10β− 1) × 100). The findings from GUSTO study were replicated in the Barwon Infant Study (BIS) cohort. As described before, linear regression was applied to investigate the association between ppBMI and antenatal lipidomic profiles (pregnant state), and the association between BW and lipidomic profiles of cord blood plasma. The ppBMI and BW results were compared between GUSTO and BIS. Scatter plots of effect sizes in two cohorts were used to highlight the linear trend and the overlapping lipid species in the two cohorts. The overlapping percentage of associated lipid species was calculated in each study. Finally, meta-analysis was performed for ppBMI and BW studies in the two cohorts using inverse variance-weighted average method [21]. Meta-analysis results were presented in forest plot and volcano plot. The lipid species with the adjusted p-value (Padj) < 0.05 were considered to be significantly associated with BMI. All the association analyses were implemented in MATLAB R2019b.

Results

Overview of plasma lipidomics

Demographic and anthropometric measures of the study participants are provided in Table 1. A total of 480 lipid species representing 25 lipid classes were profiled across 2491 maternal and offspring plasma samples, covering 4-time points (antenatal (n=752) and postnatal (n=650) for mothers, and at birth (n=751) and 6 years of age (n=338) for their offspring) as illustrated in Fig. 1A. The combined unsupervised principal component analysis (PCA) identified two major components, with the first explaining 56.83% of the variance, and the second explaining 12.49% of the variance in the total study population. The PCA plot showed distinct clusters of mothers during gestation and post-pregnancy (antenatal vs postnatal), and also of their offspring at birth (cord blood) and 6 years of age (Fig. 1B). The overlap in the clusters of postnatal mothers and their 6-year-old offspring indicated the emerging similarities between the pediatric and adult lipidomic profiles.

Table 1 Demographic and anthropometric characteristics of the study participants
Fig. 1
figure 1

Temporal and developmental alterations to the circulatory lipids in the GUSTO cohort: A Antenatal and postnatal plasma collection time points for mother-offspring dyads in GUSTO cohort. B PCA plot of lipidomics data (n=2491). C Postnatal vs. antenatal changes in maternal lipidomic profiles. D Comparison of maternal antenatal plasma with cord blood (CB) lipidomic profiles. E Changes in child lipidomic profiles between birth and 6 years of age. F Comparison of pediatric (6-year-old child) and adult (postnatal mothers) plasma lipidomes. The most significant lipid species based on adjusted p-values are labeled in c-f. Effect size is shown as log2 of fold change. Error bars indicate 95% confidence interval. Diamond—Padj ≥ 0.05 or |FC|≤1.5 (gray), circle—Padj <0.05 and |FC|>1.5, and square—Padj <1.00E−10 and |FC|>1.5

Comparison of mother-offspring lipidomes

Subsequent analyses characterize and compare the lipidomic profiles of antenatal and postnatal mothers and their offspring using linear regression models and paired t-test (see the “Methods” section and Additional file 1: Table S1A-C). As both results were similar (Additional file 1: Fig. S3), only the linear regression results are discussed in this section.

Alterations to maternal plasma lipidome during pregnancy

Alterations to the plasma lipids during pregnancy (antenatal vs postnatal) were assessed using linear regression models. Thirty-six percent of the profiled plasma lipids were substantially elevated in pregnancy (Fig. 1C). These primarily included phospholipids, such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylglycerol (PG), with PE showing the most significant increase. PE (16:0_16:1) showed the greatest difference in circulation (log2FC=−3.16 and Padj<1.00E−30). Docosahexaenoic acid (DHA) containing lipid species like PE (16:0_22:6) and PE (18:0_22:6) and arachidonic acid (ARA) containing PE (16:0_20:4) and PE (18:0_20:4) were also elevated (Additional file 1: Table S1B). The total PC to PE ratio was lower in pregnancy (Additional file 1: Fig. S4A). Additionally, ratios of DHA-PC to their corresponding DHA-PE species decreased by twofold or more in antenatal vs postnatal circulation (Additional file 1: Fig. S4B), suggesting DHA-PE species in maternal plasma as an important source for maternal-fetal transfer of DHA. Acylcarnitine (AC) species showed a general decrease in pregnancy. Lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), alkyllysophosphatidylcholine (LPC (O)), and alkenyllysophosphatidylcholine (LPC (P)) were also low in pregnancy. Ether-linked phospholipids including alkylphosphatidylcholine (PC(O)), alkenylphosphatidylcholine (PC(P)), alkenylphosphatidylethanolamine (PE(P)), and alkylphosphatidylethanolamine (PE(O)) did not show a significant change in antenatal compared to the postnatal plasma except PC(O-16:0/22:6) that was increased in pregnancy. Among the sphingolipids, only deoxy-ceramide lipids and SM (40:3) were significantly increased whereas Cer(d19:1/24:0) was decreased in pregnancy. Neutral lipids including triacylglycerol (TG), alkyl-diacylglycerol (TG(O)), and diacylglycerol (DG) were elevated in pregnancy. Cholesteryl esters (CE) species showed a divergent trend with a decrease in the levels of CE (20:5) whereas CE (16:1), CE (24:5), and CE (24:6) were increased in pregnancy (Additional file 1: Table S1B).

Comparison of antenatal maternal and fetal cord blood lipidomes

To develop further insights into the maternal-fetal transfer of lipids, antenatal lipidomic profiles of mothers were compared to that of the offspring cord blood. Circulating levels of 79% of the profiled lipids were substantially higher in maternal plasma than in cord blood (Fig. 1D. Concentration of all glycerophospholipid classes were lower in cord blood, while lysoglycerophospholipid classes were mostly higher with the exception of LPC(O-24:0) and LPC(O-24:1). Levels of PUFA (ARA, dihomo-γ-linolenic acid (DGLA), and DHA) containing lipid species were elevated in cord blood. The highest fold change was observed in ARA containing lipids such as LPC (20:4) and LPE (20:4) (log2FC > 2). Overall, PUFA containing LPC represented 27% of the total LPCs in cord blood, compared to 13% in antenatal maternal blood (Additional file 1: Fig. S4C), indicating a higher fetal demand for these lipids to support its growth and development. Sphingolipid lipid species were mostly low in cord blood. Acylcarnitine species were increased in cord blood. In summary, there was a generalized increase in acylcarnitines and lysophopholipids, but most of the complex lipids were present at lower levels in cord blood.

Alterations to plasma lipids in early childhood, and a comparison with the adult lipidome

To interrogate the changes in lipidomic profiles in early childhood, we compared the plasma lipidomic profiles of the child at birth with that at 6 years of age. A marked change (log2FC=−2.10 to 6.25) in the offspring lipidome was observed 6 years post-birth, with 68% of the lipids showing a relatively higher abundance, and 6% showing a lower abundance in circulation (Fig. 1E). The lipid species that were present at higher concentrations in cord blood included PUFA containing lysoglycerophospholipid species such as LPC(20:4), LPC(22:6), LPE(20:4), and LPE (22:6) as well several diacylglycerol and triacylglycerol species such as DG (16:0_22:6), TG (50:4) [NL-20:4], TG (56:8) [NL-22:6], and TG (58:8) [NL-22:6].

We also compared the 6-year-old pediatric and adult (postnatal mother: mean age 36 years) plasma lipidome using linear regression models. There was a substantial overlap between the pediatric and adult plasma lipidomic profiles, and the differences were smaller in magnitude than those observed in pregnancy, and at birth. Levels of 40 (8%) lipid species in adults, and one lipid (PE(P-18:0/22:4)) in children, were higher (Fig. 1F). The lipids with significantly increased levels in adults were phospholipid and triacylglycerol species that predominantly contained eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The PE-plasmalogen (PE(P)) species that were present at higher concentration in adults contained EPA whereas those present at higher concentration in child plasma contained adrenic acid (AdA) (Additional file 1: Table S1B).

Plasma lipids associated with mother and child adiposity, and the intergenerational link

Adiposity is often associated with the changes in plasma lipidomic profiles, though less is known about these changes in physiological states such as pregnancy and during child development. To investigate this at depth, we studied the plasma lipids associated with mother and child adiposity, and the intergenerational similarities between the two. Four different regression models were implemented to identify the lipids associated with adiposity in each study group. Forest plots and bar plots were generated to visualize % change in the concentration of lipid species and lipid classes, respectively (Fig. 2A–D; detailed in Additional file 1: Table S2). The top 20 lipid species with the directionality of association (10 positive and 10 negative) with adiposity measures in each study group are shown through volcano plots, and the overlap between the subject groups is provided in Fig. 3 and Additional file 1: Table S3. Scatter plots comparing the effect sizes and adjusted p-values in the four association studies are shown in Additional file 1: Fig. S5.

Fig. 2
figure 2

Association of maternal and child adiposity with plasma lipidomic profiles: A Association of pre-pregnancy BMI with antenatal plasma lipidome (pregnant state). B Association of maternal BMI with postnatal plasma lipidome (non-pregnant state). C Association of birth weight (BW) with cord blood plasma lipidome. D Association of child BMI with plasma lipidome at 6 years of age. The top 20 lipid species with the directionality of association (10 positive and 10 negative) with adiposity measures in each study group are shown in volcano plots. The horizontal dotted line indicates Padj=0.05 in each volcano plot. Effect sizes are shown as % change in lipid concentration per unit change in BMI, or per 100 g change in birth weight. Error bars indicate 95% confidence interval. Diamond—Padj ≥ 0.05 (gray), circle—Padj <0.05, and square—Padj <1.00E−5 in forest plots

Fig. 3
figure 3

Comparison of plasma lipidomic profiles associated with mother and child adiposity: A Pie chart comparing the percent overlap and directionality of association in the four studies. B Venn-diagram of lipids species that passed significance in the four association studies. C Effect sizes of 41 lipid species that overlapped between the four studies

Maternal adiposity and plasma lipids

As maternal weight undergoes changes during pregnancy, antenatal BMI was higher than pre-pregnancy BMI (ppBMI) in average but with strong correlation (R2=0.85, Additional File 1: Fig. S6 and Table 1). The association results of both BMIs with antenatal lipidomic profiles were also highly correlated (R2=0.99, Additional File 1: Fig. S7 and Table S2B-C). As ppBMI is the more commonly used obesity measure in the field to study pregnancy-related outcomes, only the ppBMI results are discussed in this section. All 287 lipid species (60% of total) showed significant associations with ppBMI, of which 234 had positive and 53 had negative associations (Figs. 2A and 3A). Most of the glycerophospholipids including ether-linked species showed a negative association with ppBMI, except for PUFA containing phosphatidylcholine species including PC(18:0_20:3) and PC(18:0_20:4), and phosphatidylethanolamine species such as PE(16:0_20:4), PE(18:0_20:4) and PE(18:0_22:6). Lysophosphatidylcholine species were negatively associated with maternal BMI except omega-6 fatty acid containing species including LPC(20:3) and LPC(20:4). Most of the triacylglycerol species were positively associated with ppBMI except those containing long chain fatty acids such as FA 14:0, FA 14:1, FA 16:1, and FA 18:3 that showed a negative association. Sphingolipids, including sphingomyelin, ceramide, and mono-, di-, and trihexosylceramide as well as GM3-gangliosides, were negatively associated whereas deoxy-ceramide and dihydroceramide were positively associated with ppBMI. Acylcarnitine were positively and cholesteryl esters were negatively associated with ppBMI. Similar analysis post-pregnancy identified 320 lipid species (67%), with 168 positively associated and 152 negatively associated with postnatal BMI (Figs. 2B and 3A). Glycerophospholipids showed divergent trends in associations; lipid species containing polyunsaturated omega-6 fatty acids including LPC(20:3), PC(18:0_20:3), PC(18:1_20:3), PE(18:0_20:3), PI(16:0_20:4), and PE(18:0_22:4) were positively associated with BMI. Upon comparison, 186 BMI-associated lipid species overlapped between the pregnant and non-pregnant states (Additional file 1: Table S3A). Among these, 154 lipid species (83%) showed consistent trends (Fig. 3A and Additional file 1: Fig. S8A), while the remaining 32 (17%) had opposite trends. The lipid species that showed consistent trends belonged to ether-linked phospholipid classes including PC(O), PC(P), PE(O), and PE(P) as well as LPC(O) and LPC(P) that were negatively associated. Similarly, mono-, di-, and trihexosylceramide and GM3-gangliosides were negatively associated whereas deoxy-ceramide and dihydroceramide showed positive association. Scatter plot comparing % change in the two studies showed a positive trend with R2=0.28 (Additional file 1: Fig. S5A-B). Top 20 lipid species associated with BMI in pregnant and non-pregnant states are indicated in the volcano plots in Fig. 2A, B, respectively.

Child adiposity and plasma lipids

We next examined the relationship between plasma lipids and child adiposity at birth and 6 years of age. Since the inter-individual variation in BMI at birth is subtle and a less reliable measure, we instead used birth weight (BW) as a surrogate measure for adiposity. Association analysis with cord blood plasma lipids identified 257 (53%) lipid species to be significantly associated with BW (Figs. 2C and 3A). Among these, 68 had positive and 189 had a negative association. LPC, LPC(O), LPC(P), and LPE were positively associated, while TG, TG(O), and DG were negatively associated with BW. TG species containing DHA showed strong negative association with BW, e.g.; (TG(56:8) [NL-22:6]: −5.36% change per 100 g increase and Padj=1.02E−22) whereas several LPC and LPE species containing FA 16:1 and FA 18:1 as well as omega-6 PUFA such as LPC(20:3), LPC(20:4), and LPE(20:4) were positively associated with BW. LPC(16:1) showed a strong positive association, with 3.89% increase in LPC(16:1) (sn1) (Padj=2.92E−30) and a 4.00% increase in LPC(16:1) (sn2) (Padj=8.10E−29) per 100 g of BW.

To further compare the lipids linked with adiposity at birth and in early childhood, associations between lipidomic profiles of 6-year-old children and their BMI were compared with BW-associated lipids. Plasma levels of 141 (29%, 113 high and 28 low) lipid species were substantially altered in children with higher BMI at age 6 (Figs. 2D and 3A). The number of lipid species associated with BMI in children was lower across the lipid classes except that of TG species that showed positive associations. Glycerophospholipid classes showed divergent associations; several PUFA containing species PC (16:1_20:4), PC (18:0_20:3) and PE (18:0_20:3) as well as plasmalogen species PE(P-16:0/20:3), PE(P-16:0/20:5) and PE(P-18:0/20:3) were positively associated with BMI. Although a few sphingolipid species were associated with BMI in children, SM(d18:2/14:0) showed strong positive association (6.29% change per unit BMI and Padj=9.93E−14). Furthermore, sex-stratified analysis identified several differences in association of lipidomic profiles with BW (Additional file 1: Fig. S9A-B). A higher number of lipid species were associated with BW in males (48%) as compared to females (31%). These differences were mainly driven by phospholipids including ether-linked phospholipids, acylcarnitines, diacylglycerol, and triacylglycerol species that showed a stronger association in males (Additional file 1: Table S4). Similarly, there were differences in associations of lipidomic profiles with BMI between male and female offspring at 6 years (Additional file 1: Fig. S9C-D). Comparison of BW- and 6-year BMI-associated lipids showed very different trends for most lipid classes. Around 88% of overlapping lipid species showed opposite trends and only 12 had a consistent trend (Fig. 3A, Additional file 1: Fig. S8C and Table S3C). Scatter plot of the effect sizes in two studies showed a negative trend with R2=0.31 (Additional file 1: Fig. S5E). These findings indicate that the cord blood lipidome was associated with BW; however, these associations become weaker in early childhood, potentially due to postnatal exposures (Additional file 1: Fig. S5F).

Intergenerational similarities in lipids associated with obesity risk

There is compelling evidence indicating that offspring of obese/overweight mothers bear a higher risk of having obesogenic growth trajectories and developing metabolic dysfunction/disease during their life-course [22]. Aligned with these reports, we found a significant correlation between the mothers and their offspring BMI. Having identified the plasma lipids linked with mother and child obesity, we leveraged these findings to explore the intergenerational similarities through lipid signatures. Around 138 common lipid species were associated with ppBMI and BW, with 67 showing consistent trends (Fig. 3A, Additional file 1: Fig. S8B and Table S3B). Comparison of child BMI-lipid associations with postnatal maternal-BMI lipids identified a 92% (130 of 141) overlap between the two, with consistent trends (Fig. 3A and Additional file 1: Table S3D). Scatter plot of effect sizes confirmed a positive trend and strong correlation (R2=0.75) between the two (Additional file 1: Fig. S5G-H). This observation not only confirmed the intergenerational link of obesity risk through lipidomic profiles but also indicated an early onset in childhood. To study the longitudinal and intergenerational obesogenic lipid signatures, we compared the adiposity-associated lipids in all the 4 study groups (Fig. 3A) and identified 41 overlapping lipid species (Fig. 3B, C and Additional file 1: Table S3E). The directionality of association for most of the lipids showed opposite trend between BW and the other three studies, indicating that some lipids associated with adiposity in early childhood and adulthood may be beneficial for optimal fetal growth.

Replication of obesity-linked lipid species in an ethnically diverse birth cohort

To investigate if the obesity-linked lipids were population-specific or were independent of the ethnic effects and geographical location, we compared the findings from Asian-centric GUSTO cohort in Singapore with Caucasian-centric Barwon Infant Study (BIS) from Australia (Fig. 4A). Due to the unavailability of the postnatal maternal and 6-year child plasma samples, we restricted the replication analysis to antenatal maternal blood (n=1042) and cord blood lipids (n=893). Similar to GUSTO, PCA plot of BIS data also revealed distinct clusters for antenatal maternal and offspring cord blood samples (Fig. 4B). Out of 480 lipid species profiled in GUSTO, 464 lipids were also profiled in BIS and used for subsequent association analysis with maternal ppBMI and offspring BW (Additional file 1: Table S5).

Fig. 4
figure 4

Replication of GUSTO identified ppBMI and BW lipid signatures in Barwon Infant Study (BIS). A Sample collection at two time points. B PCA plot of lipidomics data (n=1935). C Association of pre-pregnancy BMI (ppBMI) with antenatal plasma lipidome. D Scatter plot of effect sizes in GUSTO and BIS for ppBMI study. E Association of birth weight (BW) with cord blood plasma lipidome. The most significant lipid species based on adjusted p-values are labeled in C and E. Effect sizes are shown as % change in lipid concentration per unit change in BMI, or per 100 g change in birth weight. Error bars indicate 95% confidence interval. Diamond—Padj ≥ 0.05 (gray), circle—Padj <0.05, and square—Padj <1.00E−5. F Scatter plot of effect sizes in GUSTO and BIS for BW study. Red—significant in both cohorts, purple—only significant in GUSTO, yellow—only significant in BIS, and gray—not significant in both cohorts

Two hundred thirty-six lipid species showed a significant association with maternal BMI, of which 80 had positive and 156 had a negative association (Fig. 4C). One hundred seventy of 236 (72%) lipid species overlapped with BMI-lipids identified in GUSTO mothers, and 80% of 464 lipid species had the same directionality of effect sizes in the two cohorts. Comparison of effect sizes in both the cohorts showed a significant positive trend with R2=0.53, though the effect sizes were generally larger in BIS subjects (Fig. 4D). This could be due to a higher number of obese women or higher degree of metabolic dysregulation in the BIS cohort.

BW-lipid analysis identified 224 affected lipid species in BIS cord blood samples, of which 108 had positive and 116 had a negative association (Fig. 4E). 176 of 224 (79%) lipids overlapped between the two cohorts. 81% of 464 lipid species showed the same directionality of effect sizes in the two cohorts, and their effect sizes were highly correlated (R2=0.79) (Fig. 4F). Lipid species with discordant trends in the two cohorts can potentially be population-specific (Asian vs Australian). For example, SM showed a negative association with ppBMI and BW in GUSTO, while it exhibited divergent trend with ppBMI and positive association with BW in BIS.

Meta-analysis in the two cohorts identified 331 BMI- and 295 BW-associated lipid species, respectively (Additional file 1: Table S5, Fig. S10A and Fig. S10C). Top significant lipid species from the meta-analysis results are labeled in volcano plots (Additional file 1: Fig. S10B and Fig. S10D). One hundred nineteen of 138 lipid species identified in ppBMI vs BW comparison in GUSTO (Fig. 3A and Additional file 1: Table S3B) were also significant in the meta-analysis, and these also included 35 of 41 lipid species identified in the 4-group intergenerational obesity risk analysis in GUSTO (Fig. 3C).

Discussion

Cross-sectional and prospective assessment of mother and child plasma lipidomic profiles in our study provided novel insights into the antenatal and postnatal lipid species in circulation. It also identified similarities between child and adult lipidomic profiles, and the intergenerational overlap in the plasma lipids associated with adiposity. Characterization of plasma lipidomic profiles not only confirmed the previous reports on the substantial changes in the lipid levels in pregnancy [1, 23, 24], but also provided an in-depth profile of lipidomic changes covering 480 lipid species from 25 lipid classes. Around 36% of the profiled lipids increased in circulation in pregnancy, with phosphatidylethanolamine levels changing the most. Compared to the gestating mother, cord blood showed lower concentration of most lipids (79%), and higher concentration of lysophospholipids, indicating the specific developmental needs of the growing fetus. A substantial number of proteins involved in lipid metabolism are expressed in fetal tissues [25], but the fetus itself is unable to independently support and maintain the plasma lipid pools. Hence the maternal-fetal transport of lipids through placenta supports these needs of the growing fetus. A decrease in the levels of lysophospholipids but elevated levels of phospholipids in maternal circulation are suggestive of the decrease in the activity of phospholipase A2 (PLA2) and lecithin-cholesterol acyltransferase (LCAT) [26] enzymes in mid to late gestation to facilitate the placental uptake of intact phospholipids for further metabolism and transport of lyso-PL to fetus. Among the phospholipids we also observed a decrease in the PC to PE ratio, especially in the phospholipids containing PUFA, such as DHA, indicating the preference for accumulation of DHA-PE in maternal circulation. Correspondingly, we also observed higher levels of phospholipid products including DHA-LPE and DHA-LPC in cord blood. A probe into the percentage contribution of polyunsaturated fatty acid composition of lysophosphatidylcholine in cord blood plasma revealed a higher percentage of PUFA (27%) than maternal (antenatal and postnatal) and child 6-year plasma (Additional file 1: Fig. S4). Previous stable isotope labeling experiments have shown that majority of the labeled fatty acids were incorporated into phospholipids with a significant enrichment of labeled DHA in cord blood compared to maternal and placental samples [27]. The PUFA in PE and PC are predominantly present at the sn2 position of the phospholipid backbone, and the placental endothelial lipases cleave the sn1 fatty acid allowing the fetal uptake and transport of lyso-PL containing PUFA [28]. Recent studies have identified MFSD2A as the lyso-PL transporter in placenta [29] as well as brain [30]. Transporters like MFSD2A provide an insight into the maternal-fetal transfer of PUFA containing lyso-PL and their enrichment in cord blood plasma. As PUFA are particularly important for brain and retina development [31,32,33], an increase in their levels in cord blood indicates their specific requirements for the growing fetus. Overall, we demonstrate that PUFA containing phospholipids are enriched in maternal circulation, but their breakdown products (lyso-PL) are depleted in circulation, which corroborates with their placental uptake and transport to the fetus.

Among the increased lyphospholipids in cord blood we also observed an increase in several ether-linked species including LPC(O) and LPE(P). The ether-linked phospholipids are carriers of atypical and very long chain fatty acids that are primarily synthesized in peroxisomes [34]. Ether lipids have been shown to be co-regulated with cholesterol [35, 36] and sphingolipids [37], and together are involved in membrane homeostasis and membrane trafficking [38]. Similarly, several other lipids from SM, GM3-gangliosides, CE, and most of the AC were also elevated in cord blood. These data establish that maternal-fetal transport of lipids is much more complex than previously appreciated. However, detailed studies are needed to provide mechanistic insights into the transfer and metabolism of these diverse lipid species. At the same time, mother’s own metabolic requirements during pregnancy must be considered while interpreting the increase and decrease of various lipid species in maternal circulation. For example, the decrease in maternal acylcarnitine can occur either due to the increased fetal demand, increased beta-oxidation of fatty acids, or accelerated renal clearance during pregnancy [39]. Carnitine is required not only for the fetal growth and maturation, but its adequate status is also critical for the mother, as she needs sufficient amounts to support her energy metabolism during pregnancy. Blood carnitine levels are known to steadily decline during pregnancy, and its deficiency may require administration of exogenous carnitines to avoid metabolic crisis [40, 41]. Although in normal pregnancies a secondary carnitine deficiency may not be noticeable but in complicated pregnancy, this deficiency can be an additional risk factor. Further, maternal and child plasma lipidomic profiles may be influenced by genetics, microbiome, diet, and physical activity [42,43,44,45,46,47]. Modification to dietary intake in the form of food consumption and supplements has been of particular interest in pregnancy [48,49,50,51]. Diets and supplements such as omega-3 PUFA may impact the maternal plasma lipidomic profiles with a subsequent effect on the fetal lipids. However, as demonstrated here because of the diversity of the lipids in maternal and fetal circulation, not only fatty acids (PUFA) are essential but also other constituents such as choline, carnitine, methionine, and serine may play an important role as building blocks and cofactors for the synthesis of diverse lipid species.

Post-birth, significant changes were evident in the offspring plasma lipidome by 6 years of age. The early childhood lipidome also showed a strong resemblance to the postnatal plasma lipidome of the mother (adult), although there were some differences in the plasma lipidomic profiles that included an increase in around 40 lipids that mainly contained EPA and DHA. However, there were higher levels of adrenic acid containing PE-plasmalogens in children. These lipid species may represent an essential pathway of ARA utilization to meet increasing demands for neuronal growth and development in early childhood [52,53,54]. As is evident from our analyses, levels of 68% of the profiled lipid species increased in circulation with age from birth to 6 years, and 8% of lipids increased in circulation from child to adult. The changes in lipids from birth to 6 years of age (log2FC=−2.10 to 6.25) were much higher in magnitude than those observed between pediatric and adult subjects (log2FC=−0.68 to 1.18) (Fig. 1E, F). These findings indicate that lipidomic profiles are age-specific and undergo a significant change in their levels in circulation to support growth and development during early childhood.

Our study also advances current understanding of the association between lipids and adiposity, especially in the context of the mother and child, and their intergenerational link. We observed 83% of the overlapped lipid species associated with BMI in pregnant vs non-pregnant states with consistent trend, suggesting a physiological state independent association of these lipids with adiposity. Among these, all the lipid species from deoxy-ceramide, diacylglycerol, and alkyl-diacylglycerol classes showed a positive association with BMI, while ether-linked phospholipids and glycosphingolipids showed negative associations. These observations are also consistent with previous lipidomic studies of BMI in adult populations [17, 55, 56]. Several lipid species from Cer, SM, PC, PE, and LPC showed a positive or negative association with BMI in both pregnant and non-pregnant women depending on the composition of individual lipids. Notably, we also observed 17% of the overlapping BMI-associated lipids had opposite trends in pregnancy compared to the non-pregnant state. This was more apparent in 8 lipid classes (AC, CE, TG, PC, PE, PI, SM, and Cer). All the TG lipid species showed a positive association with BMI in non-pregnant state; several saturated and monounsaturated fatty acid containing TG showed a negative association with BMI in pregnancy. These TG species contained myristic acid, myristoleic acid, stearic acid, linoleic acid, and linolenic acid. Myristic acid containing LPC (14:0) and CE (14:0) also decreased with increasing ppBMI. Dietary intake of myristic acid and alpha-linolenic acid has been shown to modify plasma and erythrocyte lipid profiles [57] and increase the incorporation of DHA in cholesteryl esters [58]. In agreement with other reports in non-pregnant population, these myristic acid containing TG were positively associated with BMI in postnatal phase in our study. Studies have also shown that decreasing TG myristic levels enhanced insulin sensitivity in weight loss intervention [59]. Later phase of pregnancy is associated with increase in insulin resistance [60], necessary for maintaining increased levels of nutrients for fetal transfer, and these data suggest that obesity-related decrease in the levels of TG-myristic acid may alter the physiological insulin homeostasis in pregnancy. Further, the decrease in antenatal plasma levels of several phospholipid, sphingomyelin, and triacylglycerol lipid species in context of higher ppBMI is of particular interest. These are some of the lipid species that showed the most significant changes in antenatal vs postnatal circulation and the decrease in their circulating levels demonstrate the effects of pre-pregnancy adiposity on the plasma lipidomic profiles in pregnancy. Hence, divergent trends of lipid-BMI associations may arise due to the alterations in lipid metabolism in women during pregnancy. Future work focusing on these lipids will provide deeper mechanistic insights into the effects of obesogenic environment on lipid metabolism during gestation.

Around 53% of the cord blood lipids were associated with BW. Lysophospholipids irrespective of the subclass such as LPC, LPC(O), LPE, and LPE(P) showed a positive association with BW. Similarly, all the DG, TG, and TG(O) as well as DeoxyCer showed negative associations with BW. The associations of LPC and LPE were independent of the fatty acid chain length and degree of unsaturation, in agreement with other studies [61]. LPC (16:1) showed the most significant positive association with BW [62] and PUFA containing TG particularly those with DHA were among the most significantly negatively associated lipids. Here, we have extended these findings to several other lipid classes including ether-linked phospholipids, hexosylceramides and deoxy-ceramides. There were sex-stratified associations of cord blood lipid species with BW with more lipids showing associations in males as compared to the females. These differences were more pronounced in phospholipids including ether-linked phospholipids. Comparison of cord blood lipidomic profiles associated with birth weight showed opposite trends to that of the child 6-year-old lipidomic profiles and BMI. The plasma lipidomic profiles at 6 years of age showed sex-stratified differential association with BMI [63]. These differences were more pronounced in PUFA containing LPC that showed a higher increase in percentage with increasing BMI in females. These observations are in agreement with the previous reports on gender-related differences in associations of LPC with age [56]. Only 12% of the lipids, belonging to 6 lipid classes (AC, CE, LPC, PC, PC(P) and PI; Additional file 1: Fig. S8C) showed consistent trends in associations between offspring BW and BMI at 6 years. The divergent trends between BW-lipids and child BMI-lipids could be due the metabolic adaptations to the change in nutrition from in utero maternal supply to intermittent feeding and subsequent changes to the composition of diet in early childhood. Notably, lipid species associated with child BMI were very similar to those associated with adult BMI, although the later was associated with a large number of lipids (67%). This overlap in the effects of adiposity on 6-year-old child and postnatal mothers may be influenced by the similarities in the diet apart from other factors such as genetics and shared lifestyle. At the same time, the distinction in the child and adult associations reflects the age-dependent effects. For example, in children, SM(d18:2/14:0), CE (16:1), PI (16:0_16:1), and PC (18:0_20:3) as well as several PUFA containing TG showed a significant positive association with BMI whereas in adults, TG containing palmitoleic acid, stearic acid, and oleic acid were the most positively associated lipids. These later TG species represent a signature of increased de novo lipogenesis (DNL). Previous studies have shown DNL in obese subjects can lead to lipotoxicity and metabolic disease [64, 65]. Several omega-6 containing lipid species were significantly associated with ppBMI, birthweight, and child BMI, suggesting these represent intergenerational signatures of obesity risk. Validation of ppBMI and BW findings in an independent birth cohort (BIS) identified lipid signatures that were both shared and unique to each cohort, although majority of the lipids(~80%) remained consistent and had the same directionality in the two cohorts.

This study has a few limitations. Our analyses and interpretations of antenatal lipids are restricted to lipid levels in mid-pregnancy, as the blood samples were collected at only one time point in the cohort. Future studies in cohorts with multiple sampling may help profile longitudinal lipid trajectories from preconception to postnatal period, and also study causal relationship between lipids and obesity risk in women. The lack of postnatal maternal and offspring 6-year blood samples in BIS limited our ability to replicate some of the findings from the GUSTO cohort. Nevertheless, comparison of the antenatal and cord blood lipidomic profiles between the two cohorts identified a significant overlap between the obesity-linked lipid signatures. Pre-pregnancy maternal weight and maternal education level were self-reported during recruitment. Hence, bias may exist in the self-reported variables. However, self-reported ppBMI was highly correlated with BMI taken during the recruitment visit in early pregnancy (Additional file 1: Fig. S6). Last, the observations in this study may be limited by lack of relevant dietary patterns/habits information.

Conclusions

In summary, we describe the population-based developmental and intergenerational landscape of the circulating lipidome. The differential levels of diverse lipid species in cord blood and their associations with BW illustrate the complexity of maternal-fetal transfer of lipids. Future studies are needed for better understanding of the complex interaction between maternal dietary intake, incorporation of fatty acids into lipid fractions and subsequent transport to the developing fetus. The lipids that were significantly different between maternal and fetal circulation were affected by pre-pregnancy BMI, highlighting the importance of managing obesity before pregnancy. Similarly, the sex-stratified associations of lipidome with adiposity measures at birth and early childhood could provide insights into sex differences in cardiometabolic disease. Thus, our study provides an important resource for future research targeting early nutritional interventions to benefit maternal and child metabolic health.

Availability of data and materials

The data supporting the findings and figures in this study are provided in the supplementary materials. Data are not publicly available due to ethical restrictions but can be obtained from the authors upon reasonable request and subject to appropriate approvals, including from the GUSTO cohort’s Executive Committee.

Abbreviations

AC:

Acylcarnitine

ARA:

Arachidonic acid

BMI:

Body mass index

CE:

Cholesteryl ester

Cer:

Ceramide

deoxyCer:

Deoxy-ceramide

DG:

Diacylglycerol

DHA:

Docosahexaenoic acid

dhCer:

Dihydroceramide

GM3:

GM3 ganglioside

Hex2Cer:

Dihexosylceramide

Hex3Cer:

Trihexosylceramide

HexCer:

Monohexosylceramide

LC-MS/MS:

Liquid chromatography mass spectrometry

LPC:

Lysophosphatidylcholine

LPC(O):

Lysoalkylphosphatidylcholine

LPC(P):

Lysoalkenylphosphatidylcholine

LPE:

Lysophosphatidylethanolamine

LPE(P):

Lysoalkenylphosphatidylethanolamine

LPI:

Lysophosphatidylinositol

NL:

Neutral loss

PC:

Phosphatidylcholine

PC(O):

Alkylphosphatidylcholine

PC(P):

Alkenylphosphatidylcholine

PE:

Phosphatidylethanolamine

PE(O):

Alkylphosphatidylethanolamine

PE(P):

Alkenylphosphatidylethanolamine

PG:

Phosphatidylglycerol

PI:

Phosphatidylinositol

SM:

Sphingomyelin

TG:

Triacylglycerol

TG(O):

Alkyl-diacylglycerol

References

  1. Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res. 1996;37(2):299–308.

    Article  CAS  PubMed  Google Scholar 

  2. Grimes SB, Wild R. Effect of pregnancy on lipid metabolism and lipoprotein levels. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext. South Dartmouth (MA)2000.

  3. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010;24(4):515–25.

    Article  CAS  PubMed  Google Scholar 

  4. Shen H, Liu X, Chen Y, He B, Cheng W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ Open. 2016;6(12):e013509.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kulkarni SR, Kumaran K, Rao SR, Chougule SD, Deokar TM, Bhalerao AJ, et al. Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care. 2013;36(9):2706–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Misra VK, Trudeau S, Perni U. Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring). 2011;19(7):1476–81.

    Article  CAS  Google Scholar 

  7. Christensen JJ, Ulven SM, Retterstol K, Narverud I, Bogsrud MP, Henriksen T, et al. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study. Atherosclerosis. 2017;266:48–57.

    Article  CAS  PubMed  Google Scholar 

  8. Geraghty AA, Alberdi G, O'Sullivan EJ, O'Brien EC, Crosbie B, Twomey PJ, et al. Maternal blood lipid profile during pregnancy and associations with child adiposity: findings from the ROLO study. PLoS One. 2016;11(8):e0161206.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16:60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Geraghty AA, Alberdi G, O'Sullivan EJ, O'Brien EC, Crosbie B, Twomey PJ, et al. Maternal and fetal blood lipid concentrations during pregnancy differ by maternal body mass index: findings from the ROLO study. BMC Pregnancy Childbirth. 2017;17(1):360.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Wang Q, Wurtz P, Auro K, Makinen VP, Kangas AJ, Soininen P, et al. Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med. 2016;14(1):205.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hellmuth C, Lindsay KL, Uhl O, Buss C, Wadhwa PD, Koletzko B, et al. Association of maternal prepregnancy BMI with metabolomic profile across gestation. Int J Obes (Lond). 2017;41(1):159–69.

    Article  CAS  Google Scholar 

  13. Rahman ML, Feng YA, Fiehn O, Albert PS, Tsai MY, Zhu Y, et al. Plasma lipidomics profile in pregnancy and gestational diabetes risk: a prospective study in a multiracial/ethnic cohort. BMJ Open Diabetes Res Care. 2021;9(1).

  14. Soh SE, Tint MT, Gluckman PD, Godfrey KM, Rifkin-Graboi A, Chan YH, et al. Cohort profile: Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort study. Int J Epidemiol. 2014;43(5):1401–9.

    Article  PubMed  Google Scholar 

  15. Vuillermin P, Saffery R, Allen KJ, Carlin JB, Tang ML, Ranganathan S, et al. Cohort Profile: The Barwon Infant Study. Int J Epidemiol. 2015;44(4):1148–60.

    Article  PubMed  Google Scholar 

  16. Alshehry ZH, Barlow CK, Weir JM, Zhou Y, McConville MJ, Meikle PJ. An efficient single phase method for the extraction of plasma lipids. Metabolites. 2015;5(2):389–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Huynh K, Barlow CK, Jayawardana KS, Weir JM, Mellett NA, Cinel M, et al. High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors. Cell. Chem Biol. 2019;26(1):71–84 e4.

    CAS  Google Scholar 

  18. Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res. 2013;54(10):2898–908.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060–83.

    Article  CAS  PubMed  Google Scholar 

  20. Pettitt DJ, Jovanovic L. Birth weight as a predictor of type 2 diabetes mellitus: the U-shaped curve. Curr Diab Rep. 2001;1(1):78–81.

    Article  CAS  PubMed  Google Scholar 

  21. Lee CH, Cook S, Lee JS, Han B. Comparison of two meta-analysis methods: inverse-variance-weighted average and weighted sum of Z-scores. Genomics Inform. 2016;14(4):173–80.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tyrrell J, Richmond RC, Palmer TM, Feenstra B, Rangarajan J, Metrustry S, et al. Genetic evidence for causal relationships between maternal obesity-related traits and birth weight. JAMA. 2016;315(11):1129–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Darmady JM, Postle AD. Lipid metabolism in pregnancy. Br J Obstet Gynaecol. 1982;89(3):211–5.

    Article  CAS  PubMed  Google Scholar 

  24. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine. 2002;19(1):43–55.

    Article  CAS  PubMed  Google Scholar 

  25. Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, et al. A draft map of the human proteome. Nature. 2014;509(7502):575–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wallentin L, Fahraeus L. Cholesterol esterification rate and its relation to lipoprotein levels in plasma in normal human pregnancy. J Lab Clin Med. 1986;107(3):216–20.

    CAS  PubMed  Google Scholar 

  27. Larque E, Demmelmair H, Gil-Sanchez A, Prieto-Sanchez MT, Blanco JE, Pagan A, et al. Placental transfer of fatty acids and fetal implications. Am J Clin Nutr. 2011;94(6 Suppl):1908S–13S.

    Article  CAS  PubMed  Google Scholar 

  28. Lindegaard ML, Olivecrona G, Christoffersen C, Kratky D, Hannibal J, Petersen BL, et al. Endothelial and lipoprotein lipases in human and mouse placenta. J Lipid Res. 2005;46(11):2339–46.

    Article  CAS  PubMed  Google Scholar 

  29. Prieto-Sanchez MT, Ruiz-Palacios M, Blanco-Carnero JE, Pagan A, Hellmuth C, Uhl O, et al. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. Clin Nutr. 2017;36(2):513–21.

    Article  CAS  PubMed  Google Scholar 

  30. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509(7501):503–6.

    Article  CAS  PubMed  Google Scholar 

  31. Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary omega-3 fatty acids modulate large-scale systems organization in the rhesus macaque brain. J Neurosci. 2014;34(6):2065–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24(1):87–138.

    Article  CAS  PubMed  Google Scholar 

  33. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev. 2004;44(6):509–38.

    Article  CAS  PubMed  Google Scholar 

  34. van den Bosch H, Schrakamp G, Hardeman D, Zomer AW, Wanders RJ, Schutgens RB. Ether lipid synthesis and its deficiency in peroxisomal disorders. Biochimie. 1993;75(3-4):183–9.

    Article  PubMed  Google Scholar 

  35. Munn NJ, Arnio E, Liu D, Zoeller RA, Liscum L. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J Lipid Res. 2003;44(1):182–92.

    Article  CAS  PubMed  Google Scholar 

  36. Honsho M, Abe Y, Fujiki Y. Dysregulation of plasmalogen homeostasis impairs cholesterol biosynthesis. J Biol Chem. 2015;290(48):28822–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Koberlin MS, Snijder B, Heinz LX, Baumann CL, Fauster A, Vladimer GI, et al. A conserved circular network of coregulated lipids modulates innate immune responses. Cell. 2015;162(1):170–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Jimenez-Rojo N, Leonetti MD, Zoni V, Colom A, Feng S, Iyengar NR, et al. Conserved functions of ether lipids and sphingolipids in the early secretory pathway. Curr Biol. 2020;30(19):3775–87 e7.

    Article  CAS  PubMed  Google Scholar 

  39. Schoderbeck M, Auer B, Legenstein E, Genger H, Sevelda P, Salzer H, et al. Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med. 1995;23(6):477–85.

    Article  CAS  PubMed  Google Scholar 

  40. Mitro SD, Wu J, Rahman ML, Cao Y, Zhu Y, Chen Z, et al. Longitudinal plasma metabolomics profile in pregnancy-a study in an ethnically diverse U.S. pregnancy cohort. Nutrients. 2021;13(9).

  41. Lindsay KL, Hellmuth C, Uhl O, Buss C, Wadhwa PD, Koletzko B, et al. Longitudinal metabolomic profiling of amino acids and lipids across healthy pregnancy. PLoS One. 2015;10(12):e0145794.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Matey-Hernandez ML, Williams FMK, Potter T, Valdes AM, Spector TD, Menni C. Genetic and microbiome influence on lipid metabolism and dyslipidemia. Physiol Genomics. 2018;50(2):117–26.

    Article  CAS  PubMed  Google Scholar 

  43. Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr. 2019;10(suppl_1):S17–30.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Szapary PO, Bloedon LT, Foster GD. Physical activity and its effects on lipids. Curr Cardiol Rep. 2003;5(6):488–92.

    Article  PubMed  Google Scholar 

  46. Clark E, Isler C, Strickland D, McMillan AG, Fang X, Kuehn D, et al. Influence of aerobic exercise on maternal lipid levels and offspring morphometrics. Int J Obes (Lond). 2019;43(3):594–602.

    Article  CAS  Google Scholar 

  47. Ramirez-Velez R, Lobelo F, Aguilar-de Plata AC, Izquierdo M, Garcia-Hermoso A. Exercise during pregnancy on maternal lipids: a secondary analysis of randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):396.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Lundqvist A, Johansson I, Wennberg A, Hultdin J, Hogberg U, Hamberg K, et al. Reported dietary intake in early pregnant compared to non-pregnant women - a cross-sectional study. BMC Pregnancy Childbirth. 2014;14:373.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Oken E, Osterdal ML, Gillman MW, Knudsen VK, Halldorsson TI, Strom M, et al. Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort. Am J Clin Nutr. 2008;88(3):789–96.

    Article  CAS  PubMed  Google Scholar 

  50. Mijatovic-Vukas J, Capling L, Cheng S, Stamatakis E, Louie J, Cheung NW, et al. Associations of diet and physical activity with risk for gestational diabetes mellitus: a systematic review and meta-analysis. Nutrients. 2018;10(6).

  51. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 2018;11:CD003402.

  52. Wijendran V, Lawrence P, Diau GY, Boehm G, Nathanielsz PW, Brenna JT. Significant utilization of dietary arachidonic acid is for brain adrenic acid in baboon neonates. J Lipid Res. 2002;43(5):762–7.

    Article  CAS  PubMed  Google Scholar 

  53. Han X, Holtzman DM, McKeel DW Jr. Plasmalogen deficiency in early Alzheimer’s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem. 2001;77(4):1168–80.

    Article  CAS  PubMed  Google Scholar 

  54. Murphy RC. Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids. Chem Res Toxicol. 2001;14(5):463–72.

    Article  CAS  PubMed  Google Scholar 

  55. Chew WS, Torta F, Ji S, Choi H, Begum H, Sim X, et al. Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence. JCI. Insight. 2019;5.

  56. Beyene HB, Olshansky G, AA TS, Giles C, Huynh K, Cinel M, et al. High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies. PLoS Biol 2020;18(9):e3000870.

  57. Dabadie H, Motta C, Peuchant E, LeRuyet P, Mendy F. Variations in daily intakes of myristic and alpha-linolenic acids in sn-2 position modify lipid profile and red blood cell membrane fluidity. Br J Nutr. 2006;96(2):283–9.

    Article  CAS  PubMed  Google Scholar 

  58. Dabadie H, Peuchant E, Bernard M, LeRuyet P, Mendy F. Moderate intake of myristic acid in sn-2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study. J Nutr Biochem. 2005;16(6):375–82.

    Article  CAS  PubMed  Google Scholar 

  59. Schwab U, Seppanen-Laakso T, Yetukuri L, Agren J, Kolehmainen M, Laaksonen DE, et al. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study. PLoS One. 2008;3(7):e2630.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Sonagra AD, Biradar SM, K D, Murthy DSJ. Normal pregnancy- a state of insulin resistance. J Clin Diagn Res. 2014;8(11):CC01–3.

    PubMed  PubMed Central  Google Scholar 

  61. LaBarre JL, Puttabyatappa M, Song PXK, Goodrich JM, Zhou L, Rajendiran TM, et al. Maternal lipid levels across pregnancy impact the umbilical cord blood lipidome and infant birth weight. Sci Rep. 2020;10(1):14209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Lu YP, Reichetzeder C, Prehn C, Yin LH, Yun C, Zeng S, et al. Cord blood lysophosphatidylcholine 16: 1 is positively associated with birth weight. Cell Physiol Biochem. 2018;45(2):614–24.

    Article  CAS  PubMed  Google Scholar 

  63. Burugupalli S, Smith AAT, Oshlensky G, Huynh K, Giles C, Wang T, et al. Ontogeny of circulating lipid metabolism in pregnancy and early childhood: a longitudinal population study. Elife. 2022;11.

  64. Eissing L, Scherer T, Todter K, Knippschild U, Greve JW, Buurman WA, et al. De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health. Nat Commun. 2013;4:1528.

    Article  PubMed  CAS  Google Scholar 

  65. Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146(3):726–35.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The GUSTO study group: Allan Sheppard, Amutha Chinnadurai, Anne Eng Neo Goh, Anne Rifkin-Graboi, Anqi Qiu, Arijit Biswas, Bee Wah Lee, Birit F.P. Broekman, Boon Long Quah, Borys Shuter, Chai Kiat Chng, Cheryl Ngo, Choon Looi Bong, Christiani Jeyakumar Henry, Cornelia Yin Ing Chee, Yam Thiam Daniel Goh, Doris Fok, Fabian Yap, George Seow Heong Yeo, Helen Chen, Hugo P S van Bever, Iliana Magiati, Inez Bik Yun Wong, Ivy Yee-Man Lau, Jeevesh Kapur, Jenny L. Richmond, Jerry Kok Yen Chan, Joanna D. Holbrook, Johan G. Eriksson, Joshua J. Gooley, Keith M. Godfrey, Kenneth Kwek, Kok Hian Tan, Krishnamoorthy Niduvaje, Leher Singh, Lin Lin Su, Lourdes Mary Daniel, Lynette P Shek, Marielle V. Fortier, Mark Hanson, Mary Foong-Fong Chong, Mary Rauff, Mei Chien Chua, Michael Meaney, Mya Thway Tint, Neerja Karnani, Ngee Lek, Oon Hoe Teoh, P. C. Wong, Peter D. Gluckman, Pratibha Agarwal, Rob M. van Dam, Salome A. Rebello, Seang-Mei Saw, Shang Chee Chong, Shirong Cai, Shu-E Soh, Sok Bee Lim, Chin-Ying Stephen Hsu, Victor Samuel Rajadurai, Walter Stunkel, Wee Meng Han, Wei Wei Pang, Yap-Seng Chong, Yin Bun Cheung, Yiong Huak Chan, and Yung Seng Lee.

We also wish to thank the study participants from GUSTO and BIS cohorts for making this project possible as well as the staff at the respective institutions for assistance in project management.

Funding

This work was supported by the A*STAR-NHMRC joint call funding (1711624031) available to NK, PJM, MRW, DB, ALP, RS, GW, and PV. Translational Clinical Research (TCR) Flagship Program on Developmental Pathways to Metabolic Disease funded by the National Research Foundation (NRF) and administered by the National Medical Research Council (NMRC), Singapore - NMRC/TCR/004-NUS/2008 provided the funding support for subject recruitment and sample and data collection in GUSTO cohort study. Additional funds for data analysis in Singapore were supported by the Strategic Positioning Fund and IAFpp funds (H17/01/a0/005) available to NK through the Agency for Science, Technology and Research (A*STAR). The Singapore Lipidomics Incubator (SLING) is supported by grants from the National University of Singapore via the Life Sciences Institute, the National Research Foundation (NRF, NRFI2015-05 and NRFSBP-P4), and the NRF and A*STAR IAF-ICP I1901E0040. This work was also supported in part by the Victorian Government’s Operational Infrastructure Support Program.

Author information

Authors and Affiliations

Authors

Contributions

NK, MRW, and PJM conceived and supervised the study. YSL, JGE, YSC, NK, and PDG contributed to the data and sample collection in GUSTO cohort. DB, ALP, RS, and PV contributed to thedata and sample collection in BIS cohort. SAM, BB, KN, DM, AR, KMLT, AKB, PJM, MRW, and NK designed and performed experimental work. SAM, LC, BB, and SJ performed the pre-processing and quality control, and LC carried out the statistical analysis and association studies in GUSTO cohort. SB, AAT, KH, and CG contributed to the data analysis in BIS cohort. SAM, LC, PJM, MRW, and NK interpreted the data and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Peter J. Meikle, Markus R. Wenk or Neerja Karnani.

Ethics declarations

Ethics approval and consent to participate

Written informed consent was obtained at recruitment, and ethics approval for the study was granted by the Institute Review Boards of both KK Women’s and Children’s Hospital (KKH) and National University Hospital (NUH), which are the Centralised Institutional Review Board of SingHealth (CIRB) under CIRB Ref: 2018/2767 and the Domain Specific Review Board of Singapore National Healthcare Group (DSRB) under DSRB Ref: D/2009/021.This study was registered under ClinicalTrials.gov on 1 July 2010 under the identifier NCT01174875. The study was conducted in accordance with the Declaration of Helsinki, and the lipidomics study was approved by the Institutional Review Board of National University of Singapore # H-17-055E.

Consent for publication

Not applicable

Competing interests

NK and YSC are part of an academic consortium that has received research funding from Abbott Nutrition, Nestec, EVOLVE Biosystems, DSM, and Danone. All other authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Fig. S1.

Outlier detection by principal component analysis of the lipidomics data at four time points. Fig. S2. Number of pairs between the participants in antenatal, postnatal, cord blood and child lipidomes. Fig. S3. Comparison of the results of linear regression and paired t-test. Fig. S4. Ratios of PC to PE levels and lysophospholipids (lyso-PL). Fig. S5. Scatter plots of effect sizes and adjusted p-values of plasma lipids associated with mother and child adiposity. Fig. S6. Correlation of pre-pregnancy, antenatal and postnatal maternal body mass indices (BMIs). Fig. S7. Scatter plot of effect sizes in the pre-pregnancy and antenatal BMI studies. Fig. S8. Overlapping plasma lipid signatures associated with mother and child adiposity. Fig. S9. Sex difference in the birth weight and child BMI studies. Fig. S10. Forest plots and volcano plots of the meta-analysis results in GUSTO and BIS for ppBMI and BW studies. Table S1A. Comparison of lipid classes across four sample groups (antenatal, postnatal, cord blood and 6-year-old child) using linear regression model. Table S1B. Comparison of lipids species across four sample groups (antenatal, postnatal, cord blood and 6-year-old child) using linear regression model. Table S1C. Comparison of lipids species across four sample groups (antenatal, postnatal, cord blood and 6-year-old child) using paired t-test. Table S2A. Association of lipid classes with BMI or BW in four sample groups (antenatal, postnatal, cord blood and 6-year-old child) in terms of levels. Table S2B. Association of lipid species with BMI or BW in four sample groups (antenatal, postnatal, cord blood and 6-year-old child) in terms of levels. Table S2C. Association of antenatal lipidomic profiles with antenatal BMI. Table S3A. The overlapping lipid species between the ppBMI and postnatal BMI studies. Table S3B. The overlapping lipid species between the ppBMI and birth weight studies. Table S3C. The overlapping lipid species between the birth weight and 6-year-old child BMI studies. Table S3D. The overlapping lipid species between the 6-year-old child BMI and adult (postnatal mother) BMI studies. Table S3E. Overlapping lipid species in the four lipid-adiposity association studies. Table S4A. Sex difference in the birth weight and child BMI studies in terms of lipid class levels. Table S4B. Sex difference in the birth weight and child BMI in terms of species levels. Table S5. Association studies of lipids with pre-pregnancy BMI and birth weight in Barwon Infant Study (BIS), and the meta-analysis results of GUSTO and BIS.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mir, S.A., Chen, L., Burugupalli, S. et al. Population-based plasma lipidomics reveals developmental changes in metabolism and signatures of obesity risk: a mother-offspring cohort study. BMC Med 20, 242 (2022). https://doi.org/10.1186/s12916-022-02432-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12916-022-02432-y

Keywords

  • Lipidomics
  • Gestation
  • Intergenerational
  • Development
  • Lipids and fatty acids
  • Metabolomics
  • Maternal-fetal
  • Adiposity